Consensus Statement of the Indian Academy of Pediatrics on Diagnosis and Management of Fragile X Syndrome in India

Anupam Sachdeva, Prachi Jain, Vinod Gunasekaran, Sunita Bijarnia Mahay, Sharmila Mukherjee, Randi J Hagerman, Suma Shankar, Seema Kapoor, Shalini N. Kedia

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Justification: Fragile X Syndrome (FXS) is the most common genetic cause of inherited intellectual disability and autism spectrum disorder (ASD). Early identification results in appropriate management and improvement in functioning. Risk assessment in other family members can lead to prevention of the disorder. This necessitated the formulation of IAP recommendations for the diagnosis and management of FXS in Indian children and adolescents. Process: The meeting on formulation of national consensus guidelines on Fragile X syndrome was organized by the Indian Academy of Pediatrics in New Delhi on 25th February, 2017. The invited experts included Pediatricians, Developmental Pediatricians, Psychiatrists, Pediatric Neurologists, Gynecologists, Geneticists, Clinical Psychologists and Remedial Educators, and representatives of Parent Organizations. Guidelines were framed after extensive discussions. A writing committee was formed that drafted the manuscript, which was circulated among members for critical appraisal, and finalized. Recommendations: The committee recommended that early diagnosis of FXS is crucial for early, timely and appropriate management. The interventions including timely occupational therapy, speech therapy and behavioral modifications help to improve the developmental potential and reduce the maladaptive behavior. Pharmacotherapy may be needed to control and improve behavioral symptoms. In addition, the emergence of targeted treatments such as low dose sertraline, metformin and /or minocycline may also be helpful for behavior, and perhaps cognition. Genetic counselling is helpful to communicate the risk for future children with FXS or permutation involvement.

Original languageEnglish (US)
Pages (from-to)221-228
Number of pages8
JournalIndian Pediatrics
Volume56
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Fragile X Syndrome
India
Consensus
Pediatrics
Guidelines
Speech Therapy
Sertraline
Behavioral Symptoms
Minocycline
Manuscripts
Occupational Therapy
Metformin
Genetic Counseling
Intellectual Disability
Cognition
Psychiatry
Early Diagnosis
Organizations
Psychology
Drug Therapy

Keywords

  • Genetic counselling
  • Intellectual deficit
  • Outcome

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Consensus Statement of the Indian Academy of Pediatrics on Diagnosis and Management of Fragile X Syndrome in India. / Sachdeva, Anupam; Jain, Prachi; Gunasekaran, Vinod; Mahay, Sunita Bijarnia; Mukherjee, Sharmila; Hagerman, Randi J; Shankar, Suma; Kapoor, Seema; Kedia, Shalini N.

In: Indian Pediatrics, Vol. 56, No. 3, 01.03.2019, p. 221-228.

Research output: Contribution to journalArticle

Sachdeva, Anupam ; Jain, Prachi ; Gunasekaran, Vinod ; Mahay, Sunita Bijarnia ; Mukherjee, Sharmila ; Hagerman, Randi J ; Shankar, Suma ; Kapoor, Seema ; Kedia, Shalini N. / Consensus Statement of the Indian Academy of Pediatrics on Diagnosis and Management of Fragile X Syndrome in India. In: Indian Pediatrics. 2019 ; Vol. 56, No. 3. pp. 221-228.
@article{daf1e0f0d79f47d8ad8ac4eb63821378,
title = "Consensus Statement of the Indian Academy of Pediatrics on Diagnosis and Management of Fragile X Syndrome in India",
abstract = "Justification: Fragile X Syndrome (FXS) is the most common genetic cause of inherited intellectual disability and autism spectrum disorder (ASD). Early identification results in appropriate management and improvement in functioning. Risk assessment in other family members can lead to prevention of the disorder. This necessitated the formulation of IAP recommendations for the diagnosis and management of FXS in Indian children and adolescents. Process: The meeting on formulation of national consensus guidelines on Fragile X syndrome was organized by the Indian Academy of Pediatrics in New Delhi on 25th February, 2017. The invited experts included Pediatricians, Developmental Pediatricians, Psychiatrists, Pediatric Neurologists, Gynecologists, Geneticists, Clinical Psychologists and Remedial Educators, and representatives of Parent Organizations. Guidelines were framed after extensive discussions. A writing committee was formed that drafted the manuscript, which was circulated among members for critical appraisal, and finalized. Recommendations: The committee recommended that early diagnosis of FXS is crucial for early, timely and appropriate management. The interventions including timely occupational therapy, speech therapy and behavioral modifications help to improve the developmental potential and reduce the maladaptive behavior. Pharmacotherapy may be needed to control and improve behavioral symptoms. In addition, the emergence of targeted treatments such as low dose sertraline, metformin and /or minocycline may also be helpful for behavior, and perhaps cognition. Genetic counselling is helpful to communicate the risk for future children with FXS or permutation involvement.",
keywords = "Genetic counselling, Intellectual deficit, Outcome",
author = "Anupam Sachdeva and Prachi Jain and Vinod Gunasekaran and Mahay, {Sunita Bijarnia} and Sharmila Mukherjee and Hagerman, {Randi J} and Suma Shankar and Seema Kapoor and Kedia, {Shalini N.}",
year = "2019",
month = "3",
day = "1",
doi = "10.1007/s13312-019-1504-8",
language = "English (US)",
volume = "56",
pages = "221--228",
journal = "Indian Pediatrics",
issn = "0019-6061",
publisher = "Springer India",
number = "3",

}

TY - JOUR

T1 - Consensus Statement of the Indian Academy of Pediatrics on Diagnosis and Management of Fragile X Syndrome in India

AU - Sachdeva, Anupam

AU - Jain, Prachi

AU - Gunasekaran, Vinod

AU - Mahay, Sunita Bijarnia

AU - Mukherjee, Sharmila

AU - Hagerman, Randi J

AU - Shankar, Suma

AU - Kapoor, Seema

AU - Kedia, Shalini N.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Justification: Fragile X Syndrome (FXS) is the most common genetic cause of inherited intellectual disability and autism spectrum disorder (ASD). Early identification results in appropriate management and improvement in functioning. Risk assessment in other family members can lead to prevention of the disorder. This necessitated the formulation of IAP recommendations for the diagnosis and management of FXS in Indian children and adolescents. Process: The meeting on formulation of national consensus guidelines on Fragile X syndrome was organized by the Indian Academy of Pediatrics in New Delhi on 25th February, 2017. The invited experts included Pediatricians, Developmental Pediatricians, Psychiatrists, Pediatric Neurologists, Gynecologists, Geneticists, Clinical Psychologists and Remedial Educators, and representatives of Parent Organizations. Guidelines were framed after extensive discussions. A writing committee was formed that drafted the manuscript, which was circulated among members for critical appraisal, and finalized. Recommendations: The committee recommended that early diagnosis of FXS is crucial for early, timely and appropriate management. The interventions including timely occupational therapy, speech therapy and behavioral modifications help to improve the developmental potential and reduce the maladaptive behavior. Pharmacotherapy may be needed to control and improve behavioral symptoms. In addition, the emergence of targeted treatments such as low dose sertraline, metformin and /or minocycline may also be helpful for behavior, and perhaps cognition. Genetic counselling is helpful to communicate the risk for future children with FXS or permutation involvement.

AB - Justification: Fragile X Syndrome (FXS) is the most common genetic cause of inherited intellectual disability and autism spectrum disorder (ASD). Early identification results in appropriate management and improvement in functioning. Risk assessment in other family members can lead to prevention of the disorder. This necessitated the formulation of IAP recommendations for the diagnosis and management of FXS in Indian children and adolescents. Process: The meeting on formulation of national consensus guidelines on Fragile X syndrome was organized by the Indian Academy of Pediatrics in New Delhi on 25th February, 2017. The invited experts included Pediatricians, Developmental Pediatricians, Psychiatrists, Pediatric Neurologists, Gynecologists, Geneticists, Clinical Psychologists and Remedial Educators, and representatives of Parent Organizations. Guidelines were framed after extensive discussions. A writing committee was formed that drafted the manuscript, which was circulated among members for critical appraisal, and finalized. Recommendations: The committee recommended that early diagnosis of FXS is crucial for early, timely and appropriate management. The interventions including timely occupational therapy, speech therapy and behavioral modifications help to improve the developmental potential and reduce the maladaptive behavior. Pharmacotherapy may be needed to control and improve behavioral symptoms. In addition, the emergence of targeted treatments such as low dose sertraline, metformin and /or minocycline may also be helpful for behavior, and perhaps cognition. Genetic counselling is helpful to communicate the risk for future children with FXS or permutation involvement.

KW - Genetic counselling

KW - Intellectual deficit

KW - Outcome

UR - http://www.scopus.com/inward/record.url?scp=85063618229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063618229&partnerID=8YFLogxK

U2 - 10.1007/s13312-019-1504-8

DO - 10.1007/s13312-019-1504-8

M3 - Article

VL - 56

SP - 221

EP - 228

JO - Indian Pediatrics

JF - Indian Pediatrics

SN - 0019-6061

IS - 3

ER -